Algorithm analyzes mammograms, signals need for more breast cancer screening
Researchers at the School of Medicine and Whiterabbit.ai have developed a software that assesses breast density and can help identify women who could benefit from additional screening.
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients.
Research proposals to address COVID-19 challenges sought
Washington University’s McDonnell International Scholars Academy and Social Policy Institute seek proposals from WashU researchers and their international partners to identify and address the challenges of COVID-19 through artificial intelligence, technology and big data. Proposals are due Feb. 26.
Brain signals decoded to determine what a person sees
Researchers at Washington University School of Medicine have used light to decode brain signals and identify what image a person sees. It could be a step toward helping people who are unable to express themselves because of brain injury or disease communicate.
Risk analysis helps contend with uncertainty of in-person activities
People now have access to better real-time information about COVID-19 infection and transmission rates, but they still have to decide what is safe to do. A new model co-authored by mathematician John McCarthy in Arts & Sciences at Washington University in St. Louis helps to contend with the uncertainty.
‘Smart’ cartilage cells programmed to release drugs when stressed
Researchers at Washington University School of Medicine have engineered cartilage cells to release an anti-inflammatory drug in response to stresses such cells undergo when they are compressed during weight bearing and movement.
How does the immune system keep tabs on the brain?
Researchers at Washington University School of Medicine have found that immune cells stationed in such sinuses monitor the brain and initiate an immune response if they detect a problem.
Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests
A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.
Kinch receives grant for clinical data work
Michael S. Kinch, associate vice chancellor and director of the Centers for Research Innovation in Biotechnology and Drug Discovery, and professor of biochemistry and molecular biophysics at the School of Medicine,, received a one-year $280,385 grant from Arnold Ventures for his research titled “CDEK: Clinical Data Experience Knowledge-base.”
Holehouse receives grant for protein analysis
Alex Holehouse, assistant professor of biochemistry and molecular biophysics at the School of Medicine, received a one-year $91,539 grant from Dewpoint Therapeutics for his research titled “Bioinformatic tools for the analysis of phase separating proteins.”
Older Stories